KYPROLIS

Human pharmaceuticals for use in the prevention of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; human pharmaceuticals for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amylodiosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders

Pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials; medical and scientific research in the fields of treatment for cancer and oncology, and in the fields of treatment of inflammation and autoimmune diseases